The Orthopaedic Implant Company Launches Intramedullary Femur Nail System

RENO, Nev.–(BUSINESS WIRE)–The Orthopaedic Implant Company (OIC) announced the launch of its Antegrade/Retrograde Intramedullary Femur Nail (ARFN) System today.

The OIC ARFN Nail System is designed to treat femoral midshaft and distal fractures, providing for both retrograde and antegrade approaches in one implant design. The nail is available in diameters of 10.0mm through 13.0mm and lengths of 300mm to 440mm. The nails feature a 1.5-meter bow for anatomic fit and 5.0mm diameter cross-lock screws for optimal implant fixation. A full carbon-fiber targeter provides for unobstructed views under fluoroscopy.

The OIC ARFN Nail is part of OIC’s high value IM Nail System and uses the same instrumentation as all IM nails from OIC. This is the second IM nail launched by OIC this year. Steve Lichtenthal, VP of Business Development, said of the launch, “The release of the OIC IM Nail line has been incredibly timely for our customers as they move to value-based clinical delivery systems. The OIC Femur Nail broadens the spectrum of fractures that can be treated while successfully meeting criteria for clinical and economic performance-based models of care.”

About Orthopaedic Implant Company: OIC entered the medical device market in 2010 with an innovative approach to delivering the highest quality implants at the lowest possible prices. OIC implants cost 50 to 60 percent less than the average market price of premium implants, saving health care systems millions of dollars a year. OIC’s high-quality, low-cost implants and products can be used for a variety of procedures, including treatment of orthopaedic trauma and spinal injuries. All OIC products are FDA approved and manufactured in FDA approved facilities.